FDA Issues Safety Communication about Risk of False Results with the Curative SARS-CoV-2 Test for COVID-19

COLA is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. Below is a link to the most recent message with information on the FDA Safety Communication about Risk of False Results with the Curative SARS-CoV-2 Test for COVID-19.

FDA Issues Safety Communication about Risk of False Results with the Curative SARS-CoV-2 Test for COVID-19

On January 4, 2021, the U.S. Food and Drug Administration (FDA) issued a safety communication about the risk of false negative results with the Curative SARS-CoV-2 test for COVID-19.

To reduce the risk of false negative results, the test should be performed according to the instructions for use. Refer to the safety communication for more specific guidance, and please share this message with your partners and colleagues who perform testing for SARS-CoV-2.